Regeneron Pharmaceuticals Corporate Presentation 2023

Regeneron Pharmaceuticals' February 2023 corporate presentation outlines the company's pipeline of investigational and marketed products including EYLEA, Dupixent, and Libtayo, along with forward-looking clinical development programs. The presentation contains financial projections, non-GAAP measures, and discusses the company's collaborations with Sanofi and Bayer across multiple therapeutic areas including ophthalmology, immunology, and oncology.